| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |